Glenmede Trust’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Glenmede Trust’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-44,300	Closed	-$89K	–	2849
2016 Q1	$89K	Hold	44,300	–	–	﹤0.01%	1355
2015 Q4	$109K	Hold	44,300	–	–	﹤0.01%	1335
2015 Q3	$115K	Buy	44,300 +14,000	+46%	+$36.5K	﹤0.01%	1336
2015 Q2	$95K	Hold	30,300	–	–	﹤0.01%	1433
2015 Q1	$86K	Hold	30,300	–	–	﹤0.01%	1513
2014 Q4	$78K	Buy	30,300 +4,900	+19%	+$21.4K	﹤0.01%	1614
2014 Q3	$189K	Buy	25,400 +5,500	+28%	+$51.4K	﹤0.01%	1192
2014 Q2	$234K	Buy	19,900 +7,200	+57%	+$76.8K	﹤0.01%	1116
2014 Q1	$147K	Buy	12,700 +1,300	+11%	+$15.3K	﹤0.01%	1281
2013 Q4	$124K	Buy	+11,400	New	+$112K	﹤0.01%	1327

Glenmede Trust's SZYM Position: Q2 2016 in Review

Glenmede Trust sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 44,300 shares — an estimated $89K sold.

Glenmede Trust first reported a position in SZYM in Q4 2013 and held it in 10 quarters. The position peaked at $234K in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

Glenmede Trust reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Glenmede Trust sold 44,300 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $89K.
Glenmede Trust first reported a position in SOLAZYME INC COM STK (DE) in Q4 2013 and held it in 10 quarters.
Glenmede Trust's SOLAZYME INC COM STK (DE) position peaked at $234K in Q2 2014.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Glenmede Trust's 13F filing for Q2 2016, filed 5 Aug 2016.